TCTMD - tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
TCT 2024 - TCTMD.com
Oct 27, 2024 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
Aug 28, 2024 · The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply.
Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 …
Dec 4, 2024 · In a head-to-head tussle between two obesity drugs, tirzepatide came out on top of semaglutide for weight loss, according to topline results from the SURMOUNT-5 trial released by Eli Lilly on Wednesday.
Slides | tctmd.com
Apr 14, 2024 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Alain Cribier’s Death Mourned, His Legacy Celebrated Around the …
Feb 19, 2024 · Cardiologists around the world are paying tribute to Alain Cribier, MD, who passed away Friday at the age of 79. Cribier is famous for having the “crazy dream” of implanting the world’s first transcatheter aortic valve in 2002 and has spent the last two decades urging out-of-the box cardiovascular innovation and promoting access to valvular care, even in parts of the …
ESC Congress 2024 - TCTMD.com
Aug 30, 2024 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
EARLY TAVR Breaks New Ground for Preemptive Treatment of …
Oct 28, 2024 · Disclosures. EARLY TAVR was sponsored by Edwards Lifesciences. Généreux reports consulting for and/or receiving speaking fees from Abbott Vascular, Abiomed, Boston Scientific, Caranx Medical, Cardiovascular System Inc, Edwards Lifesciences, GE Healthcare, iRhythm Technologies, Medtronic, OpSens, Pi-Cardiac, Puzzle Medical, Saranas, Shockwave, …
TCTMD Login - tctmd.com
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD
Nov 16, 2024 · CHICAGO, IL—Intensively treating systolic blood pressure below 120 mm Hg reduces the risk of major cardiovascular events over 4 years in patients with type 2 diabetes and hypertension compared with the standard protocol of less than 140 mm Hg, according to …